Source briefingJuly 13, 2026Health & Science
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.
What the source reports
PRAC agrees new safety information on desogestrel- and etonogestrel-containing contraceptives and Litfulo, a medicine to treat alopecia areata Desogestrel- and etonogestrel-…, Agenda Agenda of the PRAC meeting 6-9 July 2026Draft Reference Number: EMA/PRAC/141965/2026…, PRAC statistics: July 2026 , PRAC statistics: July 2026 English (EN) (174.12 KB – PDF)First published: 10/07/2026 View , Glossary Safety signal assessments.
A safety…
Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.
Source & verification
Primary source: News and press releases · July 10, 2026
FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.
Continue reading

Correction: Co-exposure to planned power outages and wildfire PM<sub>2.5</sub> and acute healthcare utilization in California: A time-stratified case-crossover study
Health Impacts of Planned Power Outages and Wildfire Smoke Exposure in California: Analysis of Recent Research Recent research published in PLOS Medicine investigates the…

Harvard-led team receives $12 million in federal funds to advance quantum computing with AI
Evidence Dossier: Harvard-Led Quantum Computing Initiative with Federal Funding What is established A collaborative research project led by Harvard University has secured $12 million…

US Tries but Fails to Dilute UN Human Rights Resolutions
US Attempts to Weaken UN Human Rights Resolutions: An Evidence Review What is established In late 2026, during sessions of the United Nations General…